Retraction Note: Cancer Cell Int (2019) 19:284 https://doi.org/10.1186/s12935-019-1007-7
The Editors-in-Chief have retracted this article. Concerns were raised regarding a number of figures, specifically:
The Editors-in-Chief therefore no longer have confidence in the results and conclusions this article.
The authors agree with this retraction.
References
Miao Y, Lu M, Yan Q, Li S, Feng Y. Inhibition of proliferation, migration, and invasion by knockdown of pyruvate kinase-M2 (PKM2) in ovarian cancer SKOV3 and OVCAR3 cells. Oncol Res. 2016;24(6):463–75. https://doi.org/10.3727/096504016X14685034103671.
Liang T, Ye X, Liu Y, Qiu X, Li Z, Tian B, Yan D. FAM46B inhibits cell proliferation and cell cycle progression in prostate cancer through ubiquitination of β-catenin. Exp Mol Med. 2018;50(12):1–12. https://doi.org/10.1038/s12276-018-0184-0.
Zhang S, Wang Y, Chen S, Li J. Silencing of cytoskeleton-associated protein 2 represses cell proliferation and induces cell cycle arrest and cell apoptosis in osteosarcoma cells. Biomed Pharmacother. 2018;106:1396–403. https://doi.org/10.1016/j.biopha.2018.07.104.
Shi J, Wang Q, Li H, Huang Q. Silencing of USP22 suppresses high glucose-induced apoptosis, ROS production and inflammation in podocytes Mol. BioSyst. 2016;12:1445–56. https://doi.org/10.1039/C5MB00722D.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Wang, B., Wang, G., Wang, Q. et al. Retraction Note: Silencing of TRIM11 suppresses the tumorigenicity of chordoma cells through improving the activity of PHLPP1/AKT. Cancer Cell Int 23, 216 (2023). https://doi.org/10.1186/s12935-023-03017-2
Accepted:
Published:
DOI: https://doi.org/10.1186/s12935-023-03017-2